MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor Zacks Equity Research 10 hrs ago MMED's MiniMed Flex is now shipping in the U.S. with Abbott's 15-day Instinct sensor, pairing discreet app control with automated insulin delivery.
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches? Indrajit Bandyopadhyay Aug 12, 2026 DexCom's broader CGM coverage, G7 15 Day rollout and rising margins support growth, but premium valuation, competition and litigation temper upside.
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026? Zacks Equity Research Aug 12, 2026 DXCM's 2026 rebound is backed by stronger growth, G7 15 Day adoption and broader CGM access, but competition and reimbursement remain key risks.
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here? Indrajit Bandyopadhyay Aug 12, 2026 DexCom's 52.5% three-month rally is backed by earnings growth and margin gains, but premium valuation, competition and litigation raise the bar.
MMED Gets Medicare Coverage for Flex and Broadens Diabetes Care Access Zacks Equity Research Jul 27, 2026 MiniMed expands Flex access to Medicare beneficiaries, widening availability of its app-controlled pump and automated insulin delivery technology.
